Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 2Sarcoma, Kaposi 1Neurofibromatosis 2 1Neurofibromatoses 1Neoplasms by Histologic Type 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1HIV Infections 1AIDS-related Kaposi sarcoma 1

Interventions

Biopsy 2emvododstat 1efineptakin alfa 1X-Rays 1Specimen Handling 1Sorafenib 1SUB1 protein, human 1Rituximab 1Polymerase Chain Reaction 1Nivolumab 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Immunohistochemistry 1Gene Expression Profiling 1Everolimus 1Daunorubicin 1Cilengitide 1CTLA-4 Antigen 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Kaposi × emvododstat × Clear all
NCT00686842 2018-06-06

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 1/2 Terminated
17 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡